Please login to the form below

Not currently logged in
Email:
Password:

Philips says it will acquire healthcare informatics firm

Royal Philips Electronics and XIMIS have revealed that Philips will acquire XIMIS, a US-based provider of a next generation Radiology Information System (RIS).

Royal Philips Electronics and XIMIS have revealed that Philips will acquire XIMIS, a US-based provider of a next generation Radiology Information System (RIS).

The transaction is scheduled to complete in Q3 2007. No financial details on the transaction have been disclosed. XIMIS will be absorbed into the Healthcare Informatics business group of Philips' Medical Systems division.

XIMIS specialises in radiology information systems and its key product is XIRIS (Extended Internet Radiology Information System) which is an industry leading web-based RIS, scaling from community hospitals up to large, multiple facilities hospitals.

Healthcare institutions across Europe, North and South America are customers of XIMIS, which employs 50 people.

"XIMIS is a company with very talented people and unique technology that will strengthen our position in Healthcare Informatics and will enable us to provide an integrated RIS-PACS solution," said Oran Muduroglu, CEO of Philips Medical Systems' Healthcare Informatics business group.

XIRIS concentrates on workflow management at radiology facilities, Philips iSite PACS concentrates on image management and distribution. As such the XIRIS solution is complementary to the Philips iSite PACS offering and will further strengthen Philips' iSite PACS market position, says the company.

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics